About this trial
Extracellular vesicles (EVs) play a key role in cell-to-cell communication. They are small vesicles that contain rich molecular cargo. Recently, they have been proposed as biomarkers for clinical diagnostics. EVs include three classes: small EVs (exosomes), large EVs (microparticles), and apoptotic bodies. Platelet-derived EVs (PEVs) are the most abundant class in human blood and can actively participate in numerous physiological and pathological processes. The information about the role of platelet exosomes in cardiovascular disease and the effect of antiplatelet agents on their release and content is very limited.
Eligibility criteria
Qualifiers
subjects without known pathologies
Disqualifiers
individuals with gastrointestinal diseases,
individuals with history of hepatic diseases,
individuals with history of urogenital diseases,
individuals with history of hematological diseases,
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Centro Cardiologico Monzino
Lead sponsor
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Collaborator